Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$47,188,946
+$16,356,193 QoQ
Shares Held
730,140
+59.4% QoQ
Ownership
0.616%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.40008765442244.ToString("F0")%
Shared 0.ToString("F0")%
None 7.59991234557756.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$2,501,400
PutShares
60,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. HALO ranks #53 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in HALO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,188,946 | 730,140 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,832,753 | 458,139 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $50,202,914 | 684,523 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,147,856 | 1,367,702 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $96,921,965 | 1,518,915 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $88,478,761 | 1,850,633 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $113,028,049 | 1,974,634 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $40,782,730 | 778,891 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $33,413,981 | 821,386 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,977,904 | 1,541,610 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $66,177,869 | 1,732,405 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $56,476,817 | 1,565,756 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $61,382,710 | 1,607,298 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $113,413,420 | 1,993,206 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $78,445,026 | 1,983,941 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $73,094,516 | 1,661,239 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $78,272,356 | 1,962,697 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $111,190,581 | 2,765,247 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $92,243,606 | 2,267,542 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $88,408,046 | 1,946,885 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $109,424,117 | 2,624,709 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $2,501,400 | 60,000 | Put | Defined | 2021-05-17 | |
| 2020-12-31 | $112,618,281 | 2,636,813 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $66,895,239 | 2,545,481 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $39,837,379 | 1,485,915 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $17,798,746 | 989,369 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||